HGH Fragment 176-191 10mg

HGH Fragment 176-191 10mg is a high-purity, research-grade synthetic peptide representing the C-terminal segment (amino acids 176–191) of human growth hormone. Designed exclusively for in-vitro and preclinical research, it is engineered to support advanced studies focused on lipolysis, fat metabolism, and adipocyte signaling pathways.

With its increased 10mg quantity, this format is ideal for extended research protocols and scalable experimental designs. Its selective activity on fat metabolism pathways makes it a preferred compound for researchers seeking precise and targeted metabolic insights.

Overview

HGH Fragment 176-191 10mg is widely recognized in research for its ability to selectively influence lipolytic pathways without the broader systemic effects associated with full-length growth hormone. It is commonly used in studies investigating fat oxidation, inhibition of lipogenesis, and adipose tissue regulation.

Researchers focused on obesity biology, metabolic disorders, and energy balance rely on this peptide for its specificity and consistent performance. Its targeted mechanism allows for more refined investigations into lipid metabolism and cellular energy utilization.

Chemical Profile

Peptide Type: Growth hormone fragment (C-terminal)
Compound: HGH Fragment 176-191
Structure: Amino acids 176–191 of hGH
Primary Function: Lipolysis and fat metabolism research

Mechanism of Action

HGH Fragment 176-191 10mg is believed to function by interacting with pathways that regulate fat metabolism, particularly those controlling lipolysis and lipogenesis in adipose tissue.

Research suggests that it may stimulate the breakdown of stored fats while inhibiting the formation of new fat cells. These actions are associated with intracellular signaling processes that influence adipocyte activity, making it highly relevant in metabolic and obesity-related research models.

Research and Experimental Applications

HGH Fragment 176-191 10mg is widely utilized in laboratory studies focused on:

• Lipolysis and fat oxidation research
• Adipogenesis and fat cell development studies
• Obesity and metabolic pathway analysis
• Lipid metabolism and energy utilization
• Adipocyte signaling and cellular response research
• Targeted fat metabolism investigations

Its selective mechanism makes it an essential compound for advanced metabolic and lipid research.

Why Researchers Choose HGH Fragment 176-191 10mg

• Higher 10mg quantity for extended and scalable research use
• Selective targeting of lipolytic pathways
• Does not exhibit full-spectrum GH activity in research models
• High purity (≥99%) for reliable and reproducible results
• Ideal for adipose tissue and metabolic studies
• Stable lyophilized form for flexible laboratory applications

Additional Research Insights

In controlled research environments, HGH Fragment 176-191 has demonstrated significant activity in pathways associated with fat breakdown and metabolic regulation. Studies suggest that it may enhance lipid utilization while reducing fat accumulation at the cellular level.

Ongoing research continues to explore its role in energy balance, adipose tissue function, and metabolic efficiency, reinforcing its importance in modern obesity and lipid metabolism studies.

Product Specifications

Product Name: HGH Fragment 176-191
Quantity: 10mg per vial
Form: Lyophilized powder
Purity: ≥99%

Storage Instructions

Store HGH Fragment 176-191 10mg in a cool, dry place away from direct light. Refrigeration is recommended to maintain stability, especially after reconstitution in research settings.

Important Notice

HGH Fragment 176-191 10mg is intended strictly for research and laboratory use only. It is not approved for human consumption, veterinary use, or therapeutic applications. All handling must be performed by qualified professionals in compliance with applicable laws and regulations.